arrow
K

Kevin J. Curran

Memorial Sloan Kettering Cancer Center
H指数:46
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry

tisagenlecleucel 在复发/难治性B-ALL患者中的真实世界数据:来自CIBMTR登记研究的亚组分析

2025-06-260
OAAI
Improved survival with model-based dosing of antithymocyte globulin in pediatric hematopoietic cell transplantation

模型指导的抗胸腺细胞球蛋白给药方案可提高儿科造血细胞移植的生存率

2025-02-210
OA
Persistent or New Cytopenias Predict Relapse Better than Routine Bone Marrow Aspirate Evaluations After Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome in Children and Young Adult Patients
2024-07-010
PRE
Mediport use as an acceptable standard for CAR T cell infusion
2023-10-270
OAAI
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia

启发研讨会第1部分: 与嵌合抗原受体T细胞治疗b细胞急性淋巴细胞白血病的儿童和年轻人预后改善相关的临床变量

2023-10-016
OAAI
Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
2023-09-131
OAAI
Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology
2023-09-012
OAAI
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
2023-06-156
OAAI
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
2023-05-1526
OAAI
Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
2023-03-016
OAAI
Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
2023-02-1729
OAAI
Durable Engraftment and Excellent Overall Survival After CD34-Selected Peripheral Blood Stem Cell Boost in Pediatric Patients With Poor Graft Function Following Allogeneic Stem Cell Transplantation

同种异体干细胞移植后移植物功能差的儿科患者CD34-Selected外周血干细胞增强后的持久植入和出色的总体生存率

2023-01-013
OAAI
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

最佳氟达拉滨淋巴细胞耗竭与CAR T细胞治疗后结局改善相关

2022-03-2557
OAAI
Antithymocyte globulin exposure in CD34 + T-cell-depleted allogeneic hematopoietic cell transplantation
2022-02-0716
OAAI
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

桥接化疗对儿童/青年复发/难治性b细胞急性淋巴细胞白血病CD19-Specific cart细胞治疗临床结局的影响

2022-02-0130
OAAI
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

复发/难治性髓外ALL的Tisagenlecleucel结局: 儿科真实世界CAR联盟报告

2022-01-2141
OAAI